Hospital News and Research

RSS

FDA approves Inspire to begin STAR clinical trial to evaluate UAS therapy for OSA

Inspire Medical Systems, a leading developer of neuro-stimulation therapies for the treatment of obstructive sleep apnea (OSA), announced today that the company has received approval from the U.S. Food and Drug Administration (FDA) to begin its STAR pivotal clinical trial. The STAR trial (Stimulation Therapy for Apnea Reduction), is a multi-center study that will evaluate both the safety and effectiveness of Inspire Upper Airway Stimulation (UAS) therapy in patients with moderate to severe obstructive sleep apnea (OSA).

30 Nov 2010

Doctors on Facebook beware!

The Australian Medical Association (AMA) released a document that details the cautions doctors and medical trainees should take while using social media to protect patient confidentiality and medical careers.

30 Nov 2010

Queensland allied health workers go on strike over pay issues

Nearly 10,000 allied health professionals of Queensland health have gone on strike for 24 hours from midnight (AEST) over a pay dispute with the government. The health workers include occupational therapists, social workers, radiographers, pharmacists, physiotherapists, speech therapists, theatre technicians and dental workers. They feel that the government’s proposed 7.5 per cent pay increase over three years is not enough.

30 Nov 2010

Canadians at increased risk for flu complications not aware of all the facts

It starts with a headache, chills or that all-over-achy feeling. It comes on quickly, yet too many Canadians ignore the rapid onset of flu symptoms. But for the millions of Canadians at increased risk for developing serious complications from the flu, including people 65 and older, pregnant women and those with chronic medical conditions like chronic obstructive pulmonary disease (COPD), asthma, heart disease and diabetes, this 'laissez faire' attitude could be putting their health in jeopardy.

30 Nov 2010

Accelr8 extends technology evaluation agreement for BACcel rapid diagnostic system

Accelr8 Technology Corporation announced that it extended its technology evaluation agreement for its BACcel™ rapid diagnostic system with a global diagnostics company. The original agreement was announced on June 17, 2010. The essential terms remain unchanged and continue the funding to Accelr8 during the extended project period.

30 Nov 2010

Neuraltus reports positive results from NP001 Phase 1 study for ALS

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1 clinical study of NP001 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).

30 Nov 2010

Intellikine and MMRC commence INK128 Phase I trial in multiple myeloma

Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a phase I trial of INK128, a novel, orally-available small molecule kinase inhibitor of the TORC1 and TORC2 complexes, in patients with multiple myeloma.

30 Nov 2010

Methodist to develop national training center for treatment of cardiovascular disease

The Methodist DeBakey Heart & Vascular Center recently received a generous gift to develop a national training center for surgical and interventional treatments for cardiovascular disease, the number one killer of Americans. The benefactor wishes to remain anonymous.

30 Nov 2010

Mindray upgrades M7 ultrasound, high performance DC-7 platforms at RSNA annual meeting

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today announced two significant upgrades for its premium M7 ultrasound and high performance DC-7 platforms at the Radiology Society of North America (RSNA) being held in Chicago, November 28 – December 2, 2010. The hand carried M7 unit (HCU), which was recently introduced in North America, will be available with an extensive variety of new transducers

From Mindray 30 Nov 2010

Increased staffing enhances patient survival in medical ICU

In a first-of-its-kind study to measure the impact of the highest recommended specialist staffing levels in an intensive care unit, researchers at the University of Maryland School of Medicine found that increased staffing by specially trained physicians and other health care professionals can enhance patient survival and enable patients to breathe sooner without assistance. The results of the study have been released online ahead of print in the journal Critical Care Medicine.

30 Nov 2010

University Hospitals receives $42 million for cancer care

Jane and Lee Seidman have donated $42 million to University Hospitals (UH) the largest gift in the Cleveland-based health system's history. In recognition of this unprecedented generosity, UH is naming the "Jane and Lee Seidman Cancer Center" in their honor.

30 Nov 2010

Cytheris' combinational therapy demonstrates possible therapeutic strategy for PML

Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.

30 Nov 2010

Prescription rates for controlled medications double for teens, young adults

Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every nine encounters.

30 Nov 2010

Northern Hospital implements EMC and VMware solutions to virtualize and consolidate IT infrastructure

EMC Corporation, the world leader in information infrastructure solutions, today announced that Northern Hospital of Surry County, a community hospital in Mount Airy, N.C. with more than 850 healthcare professionals including physicians on staff, has implemented EMC and VMware solutions to virtualize and consolidate its IT infrastructure for increased efficiency, agility and data protection.

30 Nov 2010

Finding underscores a large-scale challenge plaguing today's healthcare system

MedTera, an integrated marketing solutions company dedicated to improving education, promotion and communications in the healthcare, life sciences and pharmaceutical industries, today announced results of a survey of more than 7,000 patients about the need for better disease management education.

30 Nov 2010

Christiana Care earns NRC's 2010/2011 Consumer Choice Award as top hospital in Delaware region

Christiana Care earned the 2010/2011 Consumer Choice Award as the top hospital in the Delaware region by the National Research Corporation (NRC), a health care performance measurement company.

30 Nov 2010

Vitala non-invasive continence control device demonstrates safety in Phase 2 clinical study

Vitala™ a novel, non-invasive continence control device, demonstrated safety and efficacy in providing up to 8 hours of temporary continence to people with an end colostomy, according to results of a study published in the journal Diseases of the Colon & Rectum.

30 Nov 2010

FG-2216 drug offers new treatment option for kidney disease-related anemia

A new drug called FG-2216 can stimulate production of the hormone erythropoietin (EPO) in dialysis patients—possibly offering a new approach to treatment of kidney disease-related anemia, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

30 Nov 2010

Sante to break ground on second and third post hospital stay rehabilitation centers

Sante Partners announces that they will officially break ground on their second and third post hospital stay rehabilitation centers: Sante of Surprise and Sante of Chandler on Wednesday, December 1st at 9 a.m. and Wednesday, December 1st at 1 p.m. respectively. The facilities will be dedicated to servicing patients/guests in the prospective communities of Surprise, Sun City and Chandler with state-of-the-art physical, occupational and speech rehabilitation centers designed by Sante Partners.

30 Nov 2010

CAMH neuroscientists develop novel protein peptide for targeted treatment of depression

Neuroscientists at the Centre for Addiction and Mental Health (CAMH) have developed a protein peptide that may be a novel type of highly targeted treatment for depression with a low side-effect profile. Depression affects one in ten Canadians at some time in their lives and is a leading cause of disability worldwide.

30 Nov 2010

Hospital News and Research

FDA approves Inspire to begin STAR clinical trial to evaluate UAS therapy for OSA

Doctors on Facebook beware!

Queensland allied health workers go on strike over pay issues

Canadians at increased risk for flu complications not aware of all the facts

Accelr8 extends technology evaluation agreement for BACcel rapid diagnostic system

Neuraltus reports positive results from NP001 Phase 1 study for ALS

Intellikine and MMRC commence INK128 Phase I trial in multiple myeloma

Methodist to develop national training center for treatment of cardiovascular disease

Mindray upgrades M7 ultrasound, high performance DC-7 platforms at RSNA annual meeting

Increased staffing enhances patient survival in medical ICU

University Hospitals receives $42 million for cancer care

Cytheris' combinational therapy demonstrates possible therapeutic strategy for PML

Prescription rates for controlled medications double for teens, young adults

Northern Hospital implements EMC and VMware solutions to virtualize and consolidate IT infrastructure

Finding underscores a large-scale challenge plaguing today's healthcare system

Christiana Care earns NRC's 2010/2011 Consumer Choice Award as top hospital in Delaware region

Vitala non-invasive continence control device demonstrates safety in Phase 2 clinical study

FG-2216 drug offers new treatment option for kidney disease-related anemia

Sante to break ground on second and third post hospital stay rehabilitation centers

CAMH neuroscientists develop novel protein peptide for targeted treatment of depression

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News